Cargando…

Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kathy Y., Kulatilake, Anita, Kalafatis, Chris, Smith, Gareth, King, Jacob D., Serra-Mestres, Jordi, Huzzey, Lauren, Ng, Nicola, Kandangwa, Pooja, Elliott, Thomas, Sommerlad, Andrew, Marston, Louise, Livingston, Gill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914129/
https://www.ncbi.nlm.nih.gov/pubmed/35256037
http://dx.doi.org/10.1192/bjo.2022.31
_version_ 1784667636764770304
author Liu, Kathy Y.
Kulatilake, Anita
Kalafatis, Chris
Smith, Gareth
King, Jacob D.
Serra-Mestres, Jordi
Huzzey, Lauren
Ng, Nicola
Kandangwa, Pooja
Elliott, Thomas
Sommerlad, Andrew
Marston, Louise
Livingston, Gill
author_facet Liu, Kathy Y.
Kulatilake, Anita
Kalafatis, Chris
Smith, Gareth
King, Jacob D.
Serra-Mestres, Jordi
Huzzey, Lauren
Ng, Nicola
Kandangwa, Pooja
Elliott, Thomas
Sommerlad, Andrew
Marston, Louise
Livingston, Gill
author_sort Liu, Kathy Y.
collection PubMed
description BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier study of London mental health in-patients to examine changes in clinical guidance and practice and associated COVID-19 prevalence and outcomes between COVID-19 waves 1 and 2 (1 March to 30 April 2020 and 14 December 2020 to 15 February 2021). METHOD: We collected the 2 month period prevalence of wave 2 of COVID-19 in older (≥65 years) in-patients and those with dementia, as well as patients’ characteristics, management and outcomes, including vaccinations. We compared these results with those of our wave 1 study. RESULTS: Sites reported that routine testing and personal protective equipment were available, and routine patient isolation on admission occurred throughout wave 2. COVID-19 infection occurred in 91/358 (25%; 95% CI 21–30%) v. 131/344, (38%; 95% CI 33–43%) P < 0.001 in wave 1. Hospitals identified more asymptomatic carriers (26/91; 29% v. 16/130; 12%) and fewer deaths (12/91; 13% v. 19/131; 15%; odds ratio = 0.92; 0.37–1.81) compared with wave 1. The patient vaccination uptake rate was 49/58 (85%). CONCLUSIONS: Patients in psychiatric in-patient settings, mostly admitted without known SARS-CoV-2 infection, had a high risk of infection compared with people in the community but lower than that during wave 1. Availability of infection control measures in line with a policy of parity of esteem between mental and physical health appears to have lowered within-hospital COVID-19 infections and deaths. Cautious management of vulnerable patient groups including mental health patients may reduce the future impact of COVID-19.
format Online
Article
Text
id pubmed-8914129
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-89141292022-03-11 Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 Liu, Kathy Y. Kulatilake, Anita Kalafatis, Chris Smith, Gareth King, Jacob D. Serra-Mestres, Jordi Huzzey, Lauren Ng, Nicola Kandangwa, Pooja Elliott, Thomas Sommerlad, Andrew Marston, Louise Livingston, Gill BJPsych Open Papers BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier study of London mental health in-patients to examine changes in clinical guidance and practice and associated COVID-19 prevalence and outcomes between COVID-19 waves 1 and 2 (1 March to 30 April 2020 and 14 December 2020 to 15 February 2021). METHOD: We collected the 2 month period prevalence of wave 2 of COVID-19 in older (≥65 years) in-patients and those with dementia, as well as patients’ characteristics, management and outcomes, including vaccinations. We compared these results with those of our wave 1 study. RESULTS: Sites reported that routine testing and personal protective equipment were available, and routine patient isolation on admission occurred throughout wave 2. COVID-19 infection occurred in 91/358 (25%; 95% CI 21–30%) v. 131/344, (38%; 95% CI 33–43%) P < 0.001 in wave 1. Hospitals identified more asymptomatic carriers (26/91; 29% v. 16/130; 12%) and fewer deaths (12/91; 13% v. 19/131; 15%; odds ratio = 0.92; 0.37–1.81) compared with wave 1. The patient vaccination uptake rate was 49/58 (85%). CONCLUSIONS: Patients in psychiatric in-patient settings, mostly admitted without known SARS-CoV-2 infection, had a high risk of infection compared with people in the community but lower than that during wave 1. Availability of infection control measures in line with a policy of parity of esteem between mental and physical health appears to have lowered within-hospital COVID-19 infections and deaths. Cautious management of vulnerable patient groups including mental health patients may reduce the future impact of COVID-19. Cambridge University Press 2022-03-08 /pmc/articles/PMC8914129/ /pubmed/35256037 http://dx.doi.org/10.1192/bjo.2022.31 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Papers
Liu, Kathy Y.
Kulatilake, Anita
Kalafatis, Chris
Smith, Gareth
King, Jacob D.
Serra-Mestres, Jordi
Huzzey, Lauren
Ng, Nicola
Kandangwa, Pooja
Elliott, Thomas
Sommerlad, Andrew
Marston, Louise
Livingston, Gill
Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title_full Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title_fullStr Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title_full_unstemmed Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title_short Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
title_sort infection control and the prevalence, management and outcomes of sars-cov-2 infections in mental health wards in london, uk: lessons learned from wave 1 to wave 2
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914129/
https://www.ncbi.nlm.nih.gov/pubmed/35256037
http://dx.doi.org/10.1192/bjo.2022.31
work_keys_str_mv AT liukathyy infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT kulatilakeanita infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT kalafatischris infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT smithgareth infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT kingjacobd infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT serramestresjordi infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT huzzeylauren infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT ngnicola infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT kandangwapooja infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT elliottthomas infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT sommerladandrew infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT marstonlouise infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2
AT livingstongill infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2